We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Acambis announced that the U.S. Centers for Disease Control and Prevention (CDC) has agreed to order an additional 10 million doses of ACAM2000, the British drugmaker's investigational smallpox vaccine.
The World Bank has approved a new loan to Romania in the amount of $37.7 million for the Avian Influenza Control and Human Pandemic Preparedness and Response project.
Indian drugmaker Ranbaxy Laboratories has announced that the District Court of The Hague has handed down a decision in the company's case against Pfizer over the cholesterol-lowering drug atorvastatin, which is marketed by Pfizer as Lipitor.
AN $18m (about sh33.4b) plant belonging to Quality Chemicals will by June next year start manufacturing anti-retroviral (ARVs) and anti-malarial drugs, the company's chairman, Francis Kitaka, has said.
The Indian Pharmaceutical Association (IPA), the apex body of pharmacists in the country, is likely to oppose the Central Government's proposed move to amend Schedule K of the Drugs and Cosmetics Act to allow sale of household remedies through unlicensed outlets.
Vietnam's Health Ministry has assigned 14 hospitals in major cities to closely supervise and promptly cope with any bird flu outbreaks among people, according to local newspaper Labor.
Codexis, Inc., a privately held biotechnology company, announced it has achieved an important development milestone under a research agreement with Schering-Plough Corporation.
Indian pharmaceutical major Ranbaxy Laboratories Limited has launched Avessa (Formoterol + Fluticasone) inhalation capsules in India for the treatment of asthma.